1214 related articles for article (PubMed ID: 21669041)
1. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
2. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.
Lee HS; Bae EJ; Yi SH; Shim JW; Jo AY; Kang JS; Yoon EH; Rhee YH; Park CH; Koh HC; Kim HJ; Choi HS; Han JW; Lee YS; Kim J; Li JY; Brundin P; Lee SH
Stem Cells; 2010 Mar; 28(3):501-12. PubMed ID: 20049900
[TBL] [Abstract][Full Text] [Related]
3. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.
Lei Z; Jiang Y; Li T; Zhu J; Zeng S
J Neuropathol Exp Neurol; 2011 Sep; 70(9):736-47. PubMed ID: 21865882
[TBL] [Abstract][Full Text] [Related]
4. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression.
Shim JW; Park CH; Bae YC; Bae JY; Chung S; Chang MY; Koh HC; Lee HS; Hwang SJ; Lee KH; Lee YS; Choi CY; Lee SH
Stem Cells; 2007 May; 25(5):1252-62. PubMed ID: 17234994
[TBL] [Abstract][Full Text] [Related]
5. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons.
Park CH; Kang JS; Shin YH; Chang MY; Chung S; Koh HC; Zhu MH; Oh SB; Lee YS; Panagiotakos G; Tabar V; Studer L; Lee SH
FASEB J; 2006 Dec; 20(14):2553-5. PubMed ID: 17077287
[TBL] [Abstract][Full Text] [Related]
8. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
Carvey PM; Ling ZD; Sortwell CE; Pitzer MR; McGuire SO; Storch A; Collier TJ
Exp Neurol; 2001 Sep; 171(1):98-108. PubMed ID: 11520124
[TBL] [Abstract][Full Text] [Related]
9. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.
Grothe C; Timmer M; Scholz T; Winkler C; Nikkhah G; Claus P; Itoh N; Arenas E
Neurobiol Dis; 2004 Nov; 17(2):163-70. PubMed ID: 15474354
[TBL] [Abstract][Full Text] [Related]
11. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation.
Brederlau A; Correia AS; Anisimov SV; Elmi M; Paul G; Roybon L; Morizane A; Bergquist F; Riebe I; Nannmark U; Carta M; Hanse E; Takahashi J; Sasai Y; Funa K; Brundin P; Eriksson PS; Li JY
Stem Cells; 2006 Jun; 24(6):1433-40. PubMed ID: 16556709
[TBL] [Abstract][Full Text] [Related]
13. The induction of rat spermatogonial stem cells into neuronal-like cells and behavioral recovery following transplantation in a rat Parkinson's disease model.
Liu T; Gong Z; Hou L; Huang Y
Int J Mol Med; 2012 Feb; 29(2):239-44. PubMed ID: 22075704
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
15. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
Gu S; Huang H; Bi J; Yao Y; Wen T
Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525
[TBL] [Abstract][Full Text] [Related]
19. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
20. The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease.
Ratzka A; Kalve I; Özer M; Nobre A; Wesemann M; Jungnickel J; Köster-Patzlaff C; Baron O; Grothe C
Cell Transplant; 2012; 21(4):749-62. PubMed ID: 21929871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
